Navigation Links
Dr. Karol Sikora Accepts Appointment to MEI Healthcare Group's Board of Directors
Date:7/19/2011

CORAL SPRINGS, Fla., July 19, 2011 /PRNewswire/ -- MEI Healthcare Group, a leading provider of healthcare strategies and equipment solutions to medical facilities around the world, announced today that Dr. Karol Sikora has accepted an appointment to the company's board of directors. Sikora is the medical director of CancerPartnersUK, the largest independent cancer network in the UK, and is dean of medicine at the University of Buckingham, Britain's first independent medical school. Sikora was previously Chief of the World Health Organization's cancer programme and served as professor and chairman of the Department of Cancer Medicine at Imperial College School of Medicine. He is currently an honorary consultant oncologist at Hammersmith Hospital in London, where he served as clinical director for cancer services for 12 years, and is a fellow of Corpus Christi College in Cambridge.

"We are delighted to have Professor Sikora as a member of our board. His vision and experience on the international stage in both the public and private sectors will be a major asset to the MEI Healthcare Group," said MEI board chair Dr. Arthur Porter.

While serving at Hammersmith Hospital, Sikora chaired that facility's fundraising campaign, an appeal that raised 8m pounds Sterling to construct the Cancer Centre at Hammersmith.  Later, he became vice president for Pharmacia Corporation and managed the company's global clinical research for oncology. He is currently an adviser to the World Health Organization, the International Atomic Energy Agency (IAEA) and is a member of the UK Health Department's Expert Advisory Group on Cancer.

Sikora has published more than 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook now in its fifth edition and, most recently, The Economics of Cancer Care.  He is on the editorial board of several journals and is the founding editor of Gene Therapy and Cancer Strategy.

MEI provides business development, capital equipment funding strategies and growth consulting services to physicians, hospitals and healthcare systems worldwide.

About MEI Healthcare Group

Headquartered in Coral Springs, Fla., MEI is a comprehensive healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions. MEI and its subsidiaries, MEI Development Corporation, MEI Healthcare Capital, MEI Informatics, MEI Healthcare International and MEI Healthcare Foundation, offer its clients more than 40 years of healthcare business experience and the value-added benefits of its strategic alliances. For more information, visit http://www.mei.com

CONTACT:
Tyler Lecceadone
SeyferthPR
1-800-435-9539
Lecceadone@seyferthpr.com


'/>"/>
SOURCE MEI Healthcare Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Karolinska Development to Divest Portfolio Company
2. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
3. Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment
4. Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR)
5. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. FDA Accepts Endo Pharmaceuticals Complete Response for New Formulation of OPANA® ER
9. FDA Formally Accepts Dune Medicals MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
10. Paul Meade Accepts Invitation to Speak at AACE Annual Meeting
11. FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec 1, 2016 Research and Markets ... Delivery in Cancer - Technologies, Markets and Companies" to their ... , , ... management of cancer The market value of drug delivery ... estimates from 2015-2025 are given according to organs involved and the ...
(Date:12/2/2016)... Dec. 1, 2016 Around the corners of ... and each habitable land present over earth. Cancer has ... once in a life time this is because of ... until now. Given the steady increase in global cancer ... the spiraling healthcare costs of treatment, there is increasing ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... additional information on its previously announced Accelerated Share Repurchase (ASR) ... ... As previously announced, the Company entered into ... which the Company will repurchase $10 billion of its ordinary ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 2016 , ... Center for Autism and Related Disorders (CARD) Portland today announced ... disorder (ASD) and other developmental disabilities. The group, which is being launched with the ... the opportunity to share stories and advice, seek help, and continue their education on ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... U.S. Surgeon ... interview with Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at ... learned that medicine is about more than making diagnoses and prescribing medicine,” he states. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive ... as living proof that attitude and determination can combine into the most remarkable ... around the holidays. This campaign will offer patients a new-found hope, by seizing ...
(Date:12/2/2016)... ... ... More than half of American teens report losing their virginity before they ... child about sex related topics, less than 60 percent spoke about deeper themes like ... launch of its second edition of the “Sexual Wellness” campaign, aiming to address the ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, ... through labeling, storing, shipping and disposal. The new version is a faster and ...
Breaking Medicine News(10 mins):